This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: F Christopher Pigge: Innovator in Cancer Therapy
Introduction
F Christopher Pigge is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of cancer therapy through his innovative research and patents. His work focuses on improving theranostic performance in peptide receptor-targeted radionuclide therapy for cancers.
Latest Patents
Christopher Pigge holds a patent for a "Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers." This invention provides a carcinoma-targeting conjugate comprising specific components for the therapeutic treatment of cancer, along with methods of use.
Career Highlights
Christopher Pigge is affiliated with the University of Iowa Research Foundation, where he conducts his research. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations
He has collaborated with notable colleagues, including Dongyoul Lee and Michael K Schultz, to further enhance the impact of his research.
Conclusion
F Christopher Pigge's innovative contributions to cancer therapy highlight the importance of research and development in medical science. His patent and collaborative efforts continue to pave the way for advancements in cancer treatment.